Skip to main content
. 2022 Sep 5;25(5):422–431. doi: 10.5223/pghn.2022.25.5.422

Fig. 1. SARS-CoV-2 antibody positivity among the subgroups according to primary diagnosis. No significant difference was found between the patients and healthy controls. Bar indicates 95% confidence interval.

Fig. 1

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2, CF: cystic fibrosis, MLD: metabolic liver diseases, CD: celiac disease, AIH: autoimmune hepatitis, IBD: inflammatory bowel disease, tx: transplantation, LT: liver transplantation.